Cyxone AB
CYXO | ST
Overview
Corporate Details
- ISIN(s):
- SE0007815428 (+2 more)
- LEI:
- 54930034OH16ROAY4K87
- Country:
- Sweden
- Address:
- Hyllie Boulevard 34, 215 32 Malmö
- Website:
- https://www.cyxone.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Cyxone AB develops disease-modifying therapies for autoimmune diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cyxone AB filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Cyxone AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cyxone AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-06-28 | Carl Magnus Högerkorp | Other | Buy | 64,950 | 40,788.60 SEK |
| 2023-06-27 | Carl Magnus Högerkorp | Other | Buy | 6,050 | 3,690.50 SEK |
| 2023-03-03 | Carl Magnus Högerkorp | Other | Buy | 100,010 | 51,005.10 SEK |
| 2023-03-02 | Carl Magnus Högerkorp | Other | Buy | 10,873 | 5,653.96 SEK |
| 2021-07-15 | Bert Junno | Other | Other | 1,788,732 | 7,763,096.88 SEK |
| 2021-07-15 | Bert Junno | Other | Other | 1,788,732 | N/A |
| 2021-07-14 | Bert Junno | Other | Other | 1,788,786 | 7,790,163.03 SEK |
| 2021-07-14 | Bert Junno | Other | Other | 1,788,786 | N/A |
| 2021-07-12 | Mikeoo Holding AB | Other | Other | 1,788,732 | 7,441,125.12 SEK |
| 2021-07-12 | Mikael Lindstam | Other | Other | 1,788,732 | N/A |
Peer Companies
Company
Country
Ticker
View
A CRO running human challenge trials to test infectious disease vaccines for pharma/biotech clients.
United Kingdom
HVO
United Kingdom
HVO
Develops inhaled therapies and patented dry powder inhalers for global pharma partners.
Sweden
ICO
Sweden
ICO
Develops novel peptide therapeutics for autoimmune diseases like Lupus (SLE) and CIDP.
United Kingdom
IMM
United Kingdom
IMM
Inhalation research instruments and CRO services for preclinical pharma/biotech development.
Sweden
ISAB
Sweden
ISAB
Clinical-stage firm developing drugs for nervous system disorders like ED & trigeminal neuralgia.
Denmark
INIT
Denmark
INIT
AI-powered neuroimaging and biomarker analytics for neurological clinical trials.
United Kingdom
IXI
United Kingdom
IXI
A CDRO specializing in generic injectable and topical drugs for the North American market.
Estonia
JML
Estonia
JML
Engineering patented, high-efficiency transmissions for vehicles and industrial drivelines.
Belgium
MLMAZ
Belgium
MLMAZ
Clinical-stage pharma firm developing tumor-directed therapies for high-need cancer patients.
Sweden
MVIR
Sweden
MVIR